US research roundup: Arxis, Cigna, Vylor
ARXS•Analysts revised ratings and price targets for several U.S.-listed companies on Friday. RBC raised Arxis to outperform from sector perform and its target to $60 from $50; Piper Sandler raised Cigna’s target to $370 from $346; RBC initiated Vylor at outperform with an $85 target.
1. Selected analyst actions
RBC raised its rating on Arxis to outperform from sector perform and its price target to $60 from $50. Piper Sandler raised its Cigna target to $370 from $346, while RBC initiated coverage of Vylor with an outperform rating and an $85 price target.
2. Other highlighted targets
New Street Research raised its Amazon target to $385 from $350. Piper Sandler raised its Nasdaq target to $108 from $104.
